-
-
A412451-100mgInformationAdomeglivant Adomeglivant (LY2409021) is a potent and selective antagonist of glukagon receptor that is used as a chronic treatment for type 2 diabetes.Adomeglivant (LY2409021) is a potent, selective glukagon receptor (GluR) allosteric
-
A412451-10mgInformationAdomeglivant Adomeglivant (LY2409021) is a potent and selective antagonist of glukagon receptor that is used as a chronic treatment for type 2 diabetes.Adomeglivant (LY2409021) is a potent, selective glukagon receptor (GluR) allosteric
-
A412451-25mgInformationAdomeglivant Adomeglivant (LY2409021) is a potent and selective antagonist of glukagon receptor that is used as a chronic treatment for type 2 diabetes.Adomeglivant (LY2409021) is a potent, selective glukagon receptor (GluR) allosteric
-
A412451-50mgInformationAdomeglivant Adomeglivant (LY2409021) is a potent and selective antagonist of glukagon receptor that is used as a chronic treatment for type 2 diabetes.Adomeglivant (LY2409021) is a potent, selective glukagon receptor (GluR) allosteric
-
A412451-5mgInformationAdomeglivant Adomeglivant (LY2409021) is a potent and selective antagonist of glukagon receptor that is used as a chronic treatment for type 2 diabetes.Adomeglivant (LY2409021) is a potent, selective glukagon receptor (GluR) allosteric
-
-
-
-
-
-